Journal profile · Dermatology
Indian Journal of Dermatology Venereology & Leprology
ISSN 0378-6323 · eISSN 0973-3922 · Wolters Kluwer Medknow Publications · INDIA · Bimonthly
Indian Journal of Dermatology Venereology & Leprology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.22; fully open access; no APC; median 96 days to acceptance (78 articles, last 24 months); community-reported acceptance: easy; 297 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Indian Journal of Dermatology Venereology & Leprology is published by Wolters Kluwer Medknow Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Autoimmune Bullous Skin Diseases, Nail Diseases and Treatments and Genetic and rare skin diseases., together about 22.1% of its articles. Its main subfields are Dermatology. (generated from OpenAlex topic counts and CAS ranking data)
Indian Journal of Dermatology, Venereology and Leprology (IJDVL) publishes original works and findings that contribute to the advancements in the field of Clinical and Experimental Dermatology, Cutaneous Biology, Dermatological Therapeutics, Cosmetic Dermatology, Dermatopathology, Dermatosurgery, Pediatric Dermatology, Photodermatology, HIV Medicine.
From the journal's Aims & Scope
Research area (LetPub): Dermatology
Editor-in-chief General Get SetPublisher website
Editorial board by country: none in mainland China; most named India 39, Taiwan, China 1, Canada 1, Kuwait 1 (42 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Autoimmune Bullous Skin DiseasesMedicine8.3%
- Nail Diseases and TreatmentsMedicine7.1%
- Genetic and rare skin diseases.Biochemistry, Genetics and Molecular Biology6.8%
- Cancer and Skin LesionsMedicine6.4%
- Cutaneous lymphoproliferative disorders researchMedicine4.9%
- Dermatology and Skin DiseasesMedicine4.6%
- melanin and skin pigmentationBiochemistry, Genetics and Molecular Biology4.6%
- Dermatologic Treatments and ResearchMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Dermatology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbasePublisher website
Other: Index Medicus, Google Scholar, EBSCO, ProQuest, Portico, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.22LetPub ·
- Impact factor (publisher) 2024
- 3.4Publisher website ·
- 5-year impact factor (publisher)
- 3.3Publisher website ·
- CiteScore 2026-06
- 2.5LetPub ·
- CiteScore (publisher)
- 2.5Publisher website ·
- SJR 2026-06
- 0.42LetPub ·
- SNIP 2026-06
- 0.87LetPub ·
- h-index
- 39LetPub ·
- h-index
- 82OpenAlex ·
- i10-index
- 1,484OpenAlex ·
- 2-year mean citedness
- 0.91OpenAlex ·
- Self-citation rate
- 2.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 70LetPub ·
Articles by year OpenAlex count · 5,638 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 116 | 116 | 5 |
| 2025 | 297 | 297 | 190 |
| 2024 | 329 | 329 | 483 |
| 2023 | 225 | 225 | 623 |
| 2022 | 218 | 218 | 968 |
| 2021 | 358 | 358 | 2,435 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
96 daysMedian, submission to acceptance · P25–P75 62 days – 156 days
- Acceptance to online
- median 147 days (27 articles)
- Submission to online
- median 233 days
- Sample
- 78 articles with submission and acceptance dates (569 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- ≤ 5
- Reference style
- Vancouver
- Cover letter
- Required
Article types accepted11, with length limits
- book reviewAll authors must meet International Committee of Medical Journal Editors (ICMJE) authorship criteria available at https://www.icmje.org/recommendations/browse/r…Length not stated
- brief reportAll authors must meet International Committee of Medical Journal Editors (ICMJE) authorship criteria available at https://www.icmje.org/recommendations/browse/r…main text ≤ 1,500 words · references ≤ 25
- commentaryCommentaries are invited by the Editor-in-Chief on a ‘to-be’ published research paper. Please do not submit any article in the category unless you get any invit…main text ≤ 700 words · references ≤ 7
- letters to the editorAll authors must meet International Committee of Medical Journal Editors (ICMJE) authorship criteria available at https://www.icmje.org/recommendations/browse/r…main text ≤ 750 words · references ≤ 7
- meta-analysisAll authors must meet International Committee of Medical Journal Editors (ICMJE) authorship criteria available at https://www.icmje.org/recommendations/browse/r…main text ≤ 5,000 words
- narrative reviewAll authors must meet International Committee of Medical Journal Editors (ICMJE) authorship criteria available at https://www.icmje.org/recommendations/browse/r…Length not stated
- original articleAll authors must meet International Committee of Medical Journal Editors (ICMJE) authorship criteria available at https://www.icmje.org/recommendations/browse/r…main text ≤ 500 words · abstract ≤ 500 words
- review articlesubmission is that of original article. Review Article Systematic critical assessments of literature and data sources of about 3000 words should be submitted on…main text ≤ 3,000 words · abstract ≤ 300 words
- short reviewsidered. No abstract is required. Focus Short reviews (up to 1500 words) on instruments, equipment, drugs or procedures of currentmain text ≤ 1,500 words
- systematic reviewAll authors must meet International Committee of Medical Journal Editors (ICMJE) authorship criteria available at https://www.icmje.org/recommendations/browse/r…main text ≤ 3,000 words
- viewpointAll authors must meet International Committee of Medical Journal Editors (ICMJE) authorship criteria available at https://www.icmje.org/recommendations/browse/r…main text ≤ 1,000 words · references ≤ 5
Policy excerpts from the journal's websiteConflicts of interest, License & copyright, Open access, Peer review, Plagiarism, Trial registration / reporting guidelines
- Conflicts of interest Conflicts of Interest/Competing Interests
All authors must disclose any and all conflicts of interest they may have with the publication of the manuscript or any institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose any conflict of interest with products that compete with those mentioned in their manuscript.
Source ↗Publisher website ·- License & copyright Copyright and Open Access Statement
All of the content published in the Indian Journal of Dermatology, Venereology and Leprology is protected under the International copyright law, defined by Creative Commons and International Council of Medical Journal Editors (ICMJE). The author of an article retains the academic copyright of the content and can self-archive the article. The journal retains the commercial rights of the published c…
Source ↗Publisher website ·- Open access Copyright and Open Access Statement
All of the content published in the Indian Journal of Dermatology, Venereology and Leprology is protected under the International copyright law, defined by Creative Commons and International Council of Medical Journal Editors (ICMJE). The author of an article retains the academic copyright of the content and can self-archive the article. The journal retains the commercial rights of the published c…
Source ↗Publisher website ·- Peer review Review Process
IJDVL has a highly rigorous peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel and important. Authors disclose all conflicts, affiliations and financial associations such that the published content is not biased.
Source ↗Publisher website ·- Plagiarism Plagiarism
According to the World Association of Medical Editors Plagiarism is the use of other’s published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. The intent and effect of plagiarism are to mislead the reader as to the contributions of the plagiarizer. This applies …
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting Guidelines
Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement. Reporting Guidelines for Specific manuscript types are given below. A statement of compliance with the approp…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Medknow Publications
- Country or region
- INDIA
- Language
- English
- Frequency
- Bimonthly
- ISSN
- 0378-6323
- Electronic ISSN
- 0973-3922
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Indian Journal of Dermatology Venereology & Leprology
What CAS zone is Indian Journal of Dermatology Venereology & Leprology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Indian Journal of Dermatology Venereology & Leprology is in Zone 4 of Medicine, and in Zone 4 of the minor category Dermatology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Indian Journal of Dermatology Venereology & Leprology?
The latest impact factor listed by LetPub is 3.22; CiteScore 2.5, h-index 82.
How long does peer review take at Indian Journal of Dermatology Venereology & Leprology?
Based on the dates recorded on 78 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 96 days (interquartile range 62–156 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Indian Journal of Dermatology Venereology & Leprology?
According to the journal's author guidelines: Keywords: ≤ 5; Reference style: Vancouver; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Indian Journal of Dermatology Venereology & Leprology based?
Of the 42 board members whose country the journal's board page names, none are in mainland China; the countries named most often are India (39), Taiwan, China (1) and Canada (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Indian Journal of Dermatology Venereology & Leprology?
According to LetPub and DOAJ records, Indian Journal of Dermatology Venereology & Leprology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE and Embase; that list has not been checked against each database.
Is Indian Journal of Dermatology Venereology & Leprology open access, and what is the APC?
Indian Journal of Dermatology Venereology & Leprology is a fully open-access journal. It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .